Get the Stockscreener App
44.84
0.99%
-0.465
Omnicell Inc stock is traded at $44.84, with a volume of 379.85K.
It is down -0.99% in the last 24 hours and up +16.61% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$45.30
Open:
$45.3
24h Volume:
379.85K
Relative Volume:
0.81
Market Cap:
$2.01B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
89.67
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
-3.34%
1M Performance:
+16.61%
6M Performance:
+50.50%
1Y Performance:
+1.20%
1-Day Range:
$44.17
$45.82
1-Week Range:
$44.17
$46.42
52-Week Range:
$22.66
$47.69
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
44.85 | 2.03B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
219.03 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
62.24 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.47 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.73 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.46 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell shares climb 4% after strong Q3 beat and raised 2025 outlook - MSN
Implied volatility surging for Omnicell stock options - MSN
Implied Volatility Surging for Omnicell Stock Options - sharewise.com
There's No Escaping Omnicell, Inc.'s (NASDAQ:OMCL) Muted Revenues Despite A 27% Share Price Rise - 富途牛牛
Omnicell (NASDAQ:OMCL) Has Some Difficulty Using Its Capital Effectively - Yahoo Finance
Omnicell, Inc. $OMCL Shares Sold by Squarepoint Ops LLC - MarketBeat
Omnicell, Inc. $OMCL Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
How Omnicell Inc. stock benefits from strong dollar2025 Momentum Check & Community Trade Idea Sharing Platform - Улправда
Will Omnicell Inc. stock attract more institutional investors2025 Major Catalysts & Risk Managed Trade Strategies - Улправда
Omnicell (OMCL) Gets a Buy from Piper Sandler - The Globe and Mail
Bank Watch: Why Omnicell Inc. stock is considered a top pickCEO Change & Smart Investment Allocation Insights - Улправда
Why Omnicell Inc. stock could rally in 2025Long Setup & Verified High Yield Trade Plans - Улправда
Geopolitics Watch: Will Omnicell Inc. stock attract more institutional investorsWeekly Trend Report & Technical Pattern Recognition Alerts - Улправда
How supply chain issues affect Omnicell Inc. stockWeekly Trend Report & AI Enhanced Trading Signals - Улправда
First Week of August 2026 Options Trading For Omnicell (OMCL) - Nasdaq
Will Omnicell Inc. stock benefit from AI adoptionMarket Risk Report & Intraday High Probability Alerts - Bölüm Sonu Canavarı
Trend Recap: Is Omnicell Inc. stock a top pick in earnings seasonChart Signals & Weekly Chart Analysis and Trade Guides - Улправда
Earnings Beat: Why Omnicell Inc. stock could rally in 2025Trade Entry Report & Expert-Curated Trade Recommendations - Улправда
Texas Permanent School Fund Corp Decreases Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Is Omnicell Inc. stock a top pick in earnings seasonMarket Risk Summary & AI Powered Market Entry Ideas - Улправда
The Bull Case For Omnicell (OMCL) Could Change Following Titan XT AI Medication Platform Launch - simplywall.st
VP Manley Sells 278 ($12K) Of Omnicell Inc [OMCL] - TradingView — Track All Markets
Omnicell (OMCL) EVP reports small share sale and RSU tax withholding - Stock Titan
Omnicell (OMCL) CEO Randall Lipps discloses tax withholding of RSU shares - Stock Titan
Best Momentum Stocks to Buy for Dec. 16 - Yahoo Finance
VP Manley Files To Sell 278 Of Omnicell Inc [OMCL] - TradingView — Track All Markets
Omnicell, Inc. $OMCL Stock Holdings Raised by Liontrust Investment Partners LLP - MarketBeat
OMCL6251486 Latest News and Headlines - TradingView — Track All Markets
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sentiment Review: Is Omnicell Inc stock cheap compared to fundamentalsJuly 2025 Update & Weekly High Momentum Picks - moha.gov.vn
Omnicell Shares Surge on Robust Earnings and Strategic Product Launch - AD HOC NEWS
Analyst Calls: Will Omnicell Inc stock benefit from AI adoptionJuly 2025 Price Swings & Reliable Trade Execution Plans - moha.gov.vn
Omnicell (NASDAQ:OMCL) Downgraded to Hold Rating by Zacks Research - MarketBeat
Federated Hermes Inc. Reduces Holdings in Omnicell, Inc. $OMCL - MarketBeat
Is Omnicell (OMCL) Expanding OmniSphere Into Nursing Units Enough To Reinforce Its Moat? - Yahoo Finance
Pharmacy Automation Systems Market to Reach US$ 12.05 Billion - openPR.com
Benchmark Maintains Omnicell (OMCL) Buy Recommendation - Nasdaq
Is Omnicell’s (OMCL) Titan XT Launch a Turning Point in Its SaaS Automation Strategy? - Sahm
Omnicell stock price target raised by BofA to $46 on new cabinet launch - Investing.com Canada
Health Systems Embrace New Strategies to Navigate Disruptions - 富途牛牛
Benchmark raises Omnicell stock price target to $50 on new Titan XT system - Investing.com Canada
Omnicell (OMCL) Stock Today: Titan XT Launch, New $50 Price Target and What It Means for 2025 Investors - ts2.tech
WINTON GROUP Ltd Makes New Investment in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Omnicell (NASDAQ:OMCL) Given New $50.00 Price Target at Benchmark - MarketBeat
American Century Companies Inc. Has $3.38 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Omnicell stock rises after launch of enterprise-level medication dispensing system - Investing.com Nigeria
Omnicell stock rises after launch of enterprise-level medication dispensing system By Investing.com - Investing.com South Africa
Omnicell Launches Advanced Titan XT Dispensing System - TipRanks
Omnicell launches Titan XT automated dispensing system for hospitals - Investing.com
Omnicell launches Titan XT automated dispensing system for hospitals By Investing.com - Investing.com South Africa
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):